Poland· PL-100186467
Gastrovit MultiActive
A medicinal product containing preparat ziołowy, registered in Poland by Phytopharm Klęka S.A..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Preparat ziołowy
- Manufacturer
- Phytopharm Klęka S.A.
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990675760
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d80cf364-bddb-4597-849a-5cf4fd55f40b GET /v1/drugs/d80cf364-bddb-4597-849a-5cf4fd55f40b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Płyn doustny",
"source": "urpl",
"strength": "-",
"packaging": "05909990675760 ¦ OTC ¦ 47485\n1 butelka 100 ml",
"substance": "Extractum compositum fluidum (0,67:1) ex Extractum compositum fluidum (0,67:1) ex Artemisiae abrotani herba, Silybi mariani fructu, Menthae piperitae folio,Cnici benedicti herba, Taraxaci radice, Millefolii herba + Menthae piperitae folium 8 cz. + Silybi mariani fructus 15 cz. + Millefolii herba 3 cz. + Taraxaci radix 3 cz. + Cnici benedicti herba 3 cz. + Artemisiae abrotani herba 35 cz.",
"common_name": "Preparat ziołowy",
"pl_product_id": "100186467",
"pozwolenie_nr": "14886",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about preparat ziołowy.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.